Rothschild Investment LLC’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368K Buy
10,394
+8,487
+445% +$251K 0.01% 697
2026
Q1
$52.8K Buy
1,907
+1,713
+883% +$44K ﹤0.01% 1095
2025
Q4
$4.21K Buy
194
+144
+288% +$2.84K ﹤0.01% 1979
2025
Q3
$757 Buy
50
+15
+43% +$186 ﹤0.01% 2700
2025
Q2
$394 Buy
35
+25
+250% +$271 ﹤0.01% 2812
2025
Q1
$101 Hold
10
﹤0.01% 2968
2024
Q4
$118 Hold
10
﹤0.01% 2888
2024
Q3
$115 Buy
+10
New +$114 ﹤0.01% 2836

Other funds holding ROIV

Rothschild Investment LLC's ROIV Position: Q2 2026 in Review

Rothschild Investment LLC increased its Roivant Sciences (ROIV) stake by 445% in Q2 2026, buying an estimated $251K and bringing the position to 10,394 shares worth $368K. The position accounts for 0.01% of the portfolio, ranked #697.

Rothschild Investment LLC first reported a position in ROIV in Q3 2024 and has held it in 8 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Rothschild Investment LLC held 10,394 shares of Roivant Sciences worth $368K as of Q2 2026.
  • Rothschild Investment LLC bought 8,487 Roivant Sciences shares in Q2 2026, an estimated $251K.
  • Roivant Sciences made up 0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #697 holding.
  • Rothschild Investment LLC first reported a position in Roivant Sciences in Q3 2024 and has held it in 8 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.